Mechanism Underlying Metformin Action and Its Potential to Reduce Gastric Cancer Risk

Diabetes mellitus is associated with a high risk of developing gastric cancer (GC). Metformin, which is conventionally used to treat type 2 diabetes, induces AMP-activated protein kinase signaling and suppresses gluconeogenesis. Recent studies have reported that metformin is associated with benefici...

Descripción completa

Detalles Bibliográficos
Autores principales: Lan, Wen-Hsi, Lin, Ting-Yu, Yeh, Jia-Ai, Feng, Chun-Lung, Hsu, Jun-Te, Lin, Hwai-Jeng, Kuo, Chia-Jung, Lai, Chih-Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695469/
https://www.ncbi.nlm.nih.gov/pubmed/36430639
http://dx.doi.org/10.3390/ijms232214163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695469/
https://www.ncbi.nlm.nih.gov/pubmed/36430639
http://dx.doi.org/10.3390/ijms232214163

Ejemplares similares